RBC Capital Downgrades Endologix (ELGX) to Sector Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. LQDA
3. BAC
4. VSTM
5. UNH
6. GS
7. JPM
8. WDAY
9. FAST
10. FFAI

Go back to RBC Capital Downgrades Endologix (ELGX) to Sector Perform

Endologix (ELGX) Tops Q2 EPS by 7c, Bumps Outlook

August 2, 2016 4:36 PM EDT

Endologix (NASDAQ: ELGX) reported Q2 EPS of ($0.13), $0.07 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $51 million versus the consensus estimate of $46.3 million.

John McDermott, Endologix Chairman and Chief Executive Officer, said, We continue to deliver solid revenue growth above expectations and are very pleased with the TriVascular mergerintegration. Our revenue performance in the second quarter was driven by strong growth with Nellix in international markets, including the... More